Eberhard Schleyer
- Hematology top 0.5%
- Genetics top 2%
- Oncology top 5%
- Molecular Biology
- Public Health, Environmental and Occupational Health top 5%
- Co-authors
- Gerhard EhningerMartin BornhäuserStefan PurscheThomas IllmerMalte von BoninWolfgang KernWolfgang HiddemannJens Freiberg‐Richter
- Topics
- Acute Lymphoblastic Leukemia research (20 papers)Chronic Lymphocytic Leukemia Research (19 papers)Acute Myeloid Leukemia Research (19 papers)
- Cited by
- HematologyGeneticsTransplantation
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Eberhard Schleyer
68 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 96
- Hematology 1.1k
- Genetics 563
- Oncology 461
- Molecular Biology 438
- Public Health, Environmental and Occupational Health 353
Countries citing papers authored by Eberhard Schleyer
This map shows the geographic impact of Eberhard Schleyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Schleyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Schleyer more than expected).
Fields of papers citing papers by Eberhard Schleyer
This network shows the impact of papers produced by Eberhard Schleyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Schleyer. The network helps show where Eberhard Schleyer may publish in the future.
Co-authorship network of co-authors of Eberhard Schleyer
This figure shows the co-authorship network connecting the top 25 collaborators of Eberhard Schleyer. A scholar is included among the top collaborators of Eberhard Schleyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eberhard Schleyer. Eberhard Schleyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 21 | |
| 3 | 31 | |
| 4 | Imatinib plus hydroxyurea versus hydroxyurea monotherapy in progressive glioblastoma (GBM) - An international open label randomised phase III study (ambrosia-study) | 2 |
| 5 | 10 | |
| 6 | 78 | |
| 7 | 35 | |
| 8 | 10 | |
| 9 | 6 | |
| 10 | 40 | |
| 11 | 134 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 34 | |
| 16 | 19 | |
| 17 | 2 | |
| 18 | 5 | |
| 19 | 25 | |
| 20 | Pharmacokinetics and protein binding of leucovorin diastereomers | 1 |
About Eberhard Schleyer
Eberhard Schleyer is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 69 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (20 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Acute Myeloid Leukemia Research (19 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (563 citations) and Transplantation (54 citations). Eberhard Schleyer has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Gerhard Ehninger, Martin Bornhäuser, Stefan Pursche, Thomas Illmer, Malte von Bonin, Wolfgang Kern, Wolfgang Hiddemann, Jens Freiberg‐Richter, Andreas Jenke and Michael Unterhalt. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.